XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Oct. 31, 2021 10,058,571      
Balance at Oct. 31, 2021 $ 101 $ 24,301 $ 15,201 $ 39,603
Exercise of stock options 1 56 0 57
Stock-based compensation expense $ 0 307 0 307
Tax withholding related to vesting of restricted stock (in shares) (2,479)      
Tax withholding related to vesting of restricted stock $ 0 (16) 0 (16)
Consolidated net loss $ 0 0 226 226
Exercise of stock options (in shares) 22,927      
Issuance of restricted stock (in shares) 39,666      
Issuance of restricted stock $ 0 0 0 0
Balance (in shares) at Apr. 30, 2022 10,118,685      
Balance at Apr. 30, 2022 $ 102 24,648 15,427 40,177
Balance (in shares) at Jan. 31, 2022 10,096,175      
Balance at Jan. 31, 2022 $ 101 24,427 14,924 39,452
Exercise of stock options 1 56 0 57
Stock-based compensation expense $ 0 168 0 168
Tax withholding related to vesting of restricted stock (in shares) (417)      
Tax withholding related to vesting of restricted stock $ 0 (3) 0 (3)
Consolidated net loss $ 0 0 503 503
Exercise of stock options (in shares) 22,927      
Issuance of restricted stock $ 0   0  
Balance (in shares) at Apr. 30, 2022 10,118,685      
Balance at Apr. 30, 2022 $ 102 24,648 15,427 40,177
Balance (in shares) at Oct. 31, 2022 10,193,287      
Balance at Oct. 31, 2022 $ 102 25,118 16,649 41,869
Exercise of stock options $ 0 85   85
Stock-based compensation expense   441   441
Tax withholding related to vesting of restricted stock (in shares) (2,002)      
Tax withholding related to vesting of restricted stock   (10)   (10)
Issuance of restricted stock   0    
Consolidated net loss     (581) $ (581)
Exercise of stock options (in shares) 45,000     45,000
Issuance of restricted stock (in shares) 54,092      
Issuance of restricted stock $ 1      
Balance (in shares) at Apr. 30, 2023 10,290,377      
Balance at Apr. 30, 2023 $ 103 25,634 16,068 $ 41,805
Balance (in shares) at Jan. 31, 2023 10,291,067      
Balance at Jan. 31, 2023 $ 103 25,408 15,487 40,998
Exercise of stock options $ 0      
Stock-based compensation expense   229   229
Tax withholding related to vesting of restricted stock (in shares) (690)      
Tax withholding related to vesting of restricted stock   (3)   (3)
Issuance of restricted stock   0    
Consolidated net loss     581 581
Balance (in shares) at Apr. 30, 2023 10,290,377      
Balance at Apr. 30, 2023 $ 103 $ 25,634 $ 16,068 $ 41,805